Neoadjuvant & Adjuvant Pembro in Locally Advanced H&N Cancer: KEYNOTE-689 Trial
Neoadjuvant & Adjuvant Pembro in Locally Advanced H&N Cancer: K…
117 views5 months ago
vumedi.com
Role of Immunotherapy in Locally Advanced Head & HNSCC: Trial Insights Including NIVOPOSTOP & KEYNOTE-689
Role of Immunotherapy in Locally Advanced Head & HNSCC: Trial In…
8 months ago
vumedi.com
Pembrolizumab KEYNOTE-689 Phase 3 Trial Update for LA-HNSCC at AACR 2025
1:05
Pembrolizumab KEYNOTE-689 Phase 3 Trial Update for LA-HNSC…
Apr 29, 2025
oncologytube.com
🎙️ Episode 10 : Pembrolizumab Reshaping Head and Neck Cancer Treatment : KEYNOTE-689 | Dr. Pidugu
15:47
🎙️ Episode 10 : Pembrolizumab Reshaping Head and Neck Cance…
399 views10 months ago
YouTubeOncoTrial Insights with Dr.Pidugu
Keynote 689 Pembrolizumab for Locally Advanced Disease 2025 Head and Neck Advances
5:10
Keynote 689 Pembrolizumab for Locally Advanced Disease 2025 H…
612 views11 months ago
YouTubeGlobal Resource for Advancing Cancer Education
ASCO® 2025 Summary: Integrating Immunotherapy in Resectable H&N Cancers - KEYNOTE-689 and NIVOPOSTOP
ASCO® 2025 Summary: Integrating Immunotherapy in Resectable H&…
386 views11 months ago
vumedi.com
ASCO® 2025 Summary: Key Trials in H&N Cancer Including NIVOPOSTOP, KEYNOTE-689, and KEYNOTE-412
ASCO® 2025 Summary: Key Trials in H&N Cancer Including NIVOPO…
110 views9 months ago
vumedi.com
48:15
Episode 1 - Dissecting NIVOPOSTOP and KEYNOTE-689
172 views3 months ago
YouTubeLet's Dissect - A Head & Neck Oncology Podcast
11:45
Keynote 689#Perioperative Pembrolizumab#Immunotherapy#…
504 viewsMay 9, 2025
YouTubeCancer education made simple # Chandrakant…
6:24
Keynote-689 trial for Cancer Treatment|| Immunotherapy|| Relie…
76 views11 months ago
YouTubeManish Dubey
KEYNOTE Trial Data Reveals Continued Efficacy of Pembrolizu…
6 months ago
archyde.com
39:01
Keynote-689: Immunotherapy for Head & Neck Cancer w/ Drs. Rode…
703 views6 months ago
YouTubeBackTable ENT
2:29
Tumore testa-collo: lo studio Keynote-689
3 views1 month ago
YouTubeHUMANITAS Research Hospital
47:54
Keynote 689: Multidisciplinary Care for Immunotherapy in Head & Nec…
126 views6 months ago
YouTubeBackTable ENT & Allergy
KEYNOTE-091 Evaluates Adjuvant Pembrolizumab in Resected Early …
Jul 19, 2022
targetedonc.com
4:34
Keynote 689: Studying the Standard of Care - Head and Neck Cancer O…
48 views6 months ago
YouTubeGlobal Resource for Advancing Cancer Education
Merck's Keytruda Meets Primary Endpoint in Late-Stage Head and …
Oct 8, 2024
marketscreener.com
Makoto Tahara, ESMO 2022: 5-year results from KEYNOTE-048 - Pem…
20 viewsSep 14, 2022
touchoncology.com
Merck & Co., Inc. Announces Phase 3 KEYNOTE-B96 Trial Met Second…
7 months ago
marketscreener.com
Dr. Harrington on the KEYNOTE-048 Trial in Recurrent/Metastatic Head …
Aug 20, 2020
onclive.com
Design, Criteria, and Endpoints of KEYNOTE 564 | Targeted Oncolog…
Nov 9, 2022
targetedonc.com
3:01
A Phase III Trial of Pembrolizumab as Adjuvant Treatment for Renal C…
642 viewsFeb 26, 2018
YouTubeTargeted Oncology
1:02:36
Cross Trial Peri Operative Immunotherapy (Keynote-689, Ch…
94 views1 month ago
YouTubeKavina Creations
Dr. Rodriguez-Abreu on Updated Results From the KEYNOTE-189 T…
Jun 5, 2020
onclive.com
Dr. Graff on the KEYNOTE-641 Trial in mCRPC | OncLive
Mar 23, 2020
onclive.com
Dr. Rodriguez-Abreu on the Final Analysis of the KEYNOTE-189 Tria…
Jun 2, 2020
onclive.com
Gilead Sciences Reports Positive Data From Phase 3 ASCENT-04/K…
Jan 26, 2008
finanznachrichten.de
Dr. Graff on the KEYNOTE-199 Trial Design in Castration-Resistant Pr…
Feb 20, 2020
onclive.com
Landmark Trials in First-Line Treatment Landscape for Advance…
Mar 5, 2025
onclive.com
8:19
KEYNOTE Trial Data: Pembrolizumab’s Role in NSCLC
261 viewsJul 23, 2018
YouTubeOncLive
See more videos
Static thumbnail place holder